Tyra Biosciences to Participate in Virtual Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series
Tyra Biosciences Inc., a clinical-stage biotechnology company, will participate in a virtual fireside chat as part of the UBS Biotech Management Live Call Series on July 25, 2025. The event will focus on achondroplasia and growth disorders, with company management including CEO Todd Harris, CMO Doug Warner, MD, and CFO Alan Fuhrman participating.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA34287) on July 21, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。